Feasibility of Fasting & Exercise in Pts With HR+ MBC
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Talazoparib in Combination With Belinostat for Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, and Metastatic Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of U3-1402 (Patritumab Deruxtecan) in Subjects With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Nurse AMIE for Echo Show: Randomized Control Trial
- Status
- COMPLETED
- Phase
- NA
A Study to Understand the Treatment Patterns and Patients and Their Clinical Outcomes Who Are Taking Palbociclib in a Real Life Setting in Israel.
- Status
- COMPLETED
- Phase
- N/A
ER+/HER2- Locally Advanced or Metastatic Breast Cancer (ENZENO Study)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
To Identify Primary Resistance to CDK4/6 Inhibitors in Breast Cancer
- Status
- RECRUITING
- Phase
- N/A
Asian Study of Sacituzumab Govitecan (IMMU-132) in HR+/HER2- Metastatic Breast Cancer (MBC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Pyrotinib Combined With Trastuzumab And Chemotherapy in HER2-positive MBC
- Status
- UNKNOWN
- Phase
- N/A
ImmunoBreast - A Phase Ib Study
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Integrated Patient Avatars for Guiding Systemic Therapy Treatments in Metastatic Breast Cancer Patients
- Status
- RECRUITING
- Phase
- N/A
ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Determinants of Acquired Endocrine Resistance in Metastatic Breast Cancer: A Pilot Study
- Status
- UNKNOWN
- Phase
- N/A
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Letrozole and Metronomic Capecitabine in ER-positive HER2 Negative Advanced Breast Cancer (B-001 Study)
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Phase 1b/2 Study of T-DXd Combinations in HER2-positive Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Real World Study Using Comprehensive Genomic Data on the Next Treatment Decision Making in Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A